A View Independent Classification Framework for Yoga Postures.

Yoga is a globally acclaimed and widely recommended practice for a healthy living. Maintaining correct posture while performing a Yogasana is of utmost importance. In this work, we employ transfer learning from human pose estimation models for extracting 136 key-points spread all over the body to train a random forest classifier which is used for estimation of the Yogasanas. The results are evaluated on an in-house collected extensive yoga video database of 51 subjects recorded from four different camera angles. We use a three step scheme for evaluating the generalizability of a Yoga classifier by testing it on (1) unseen frames, (2) unseen subjects, and (3) unseen camera angles. We argue that for most of the applications, validation accuracies on unseen subjects and unseen camera angles would be most important. We empirically analyze over three public datasets, the advantage of transfer learning and the possibilities of target leakage. We further demonstrate that the classification accuracies critically depend on the cross validation method employed and can often be misleading. To promote further research, we have made key-points dataset and code publicly available. Supplementary Information: The online version contains supplementary material available at 10.1007/s42979-022-01376-7.

Gene expression based inference of cancer drug sensitivity.

Inter and intra-tumoral heterogeneity are major stumbling blocks in the treatment of cancer and are responsible for imparting differential drug responses in cancer patients. Recently, the availability of high-throughput screening datasets has paved the way for machine learning based personalized therapy recommendations using the molecular profiles of cancer specimens. In this study, we introduce Precily, a predictive modeling approach to infer treatment response in cancers using gene expression data. In this context, we demonstrate the benefits of considering pathway activity estimates in tandem with drug descriptors as features. We apply Precily on single-cell and bulk RNA sequencing data associated with hundreds of cancer cell lines. We then assess the predictability of treatment outcomes using our in-house prostate cancer cell line and xenografts datasets exposed to differential treatment conditions. Further, we demonstrate the applicability of our approach on patient drug response data from The Cancer Genome Atlas and an independent clinical study describing the treatment journey of three melanoma patients. Our findings highlight the importance of chemo-transcriptomics approaches in cancer treatment selection.